AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Cash & Equivalents	9,762	11,303	12,172	11,182	10,377
Cash & Short-Term Investments	9,762	11,303	12,172	11,182	10,377
Cash Growth	-13.63%	-7.14%	8.85%	7.76%	12.52%
Receivables	3,268	2,915	2,792	2,828	2,563
Inventory	7,653	7,022	5,981	4,362	3,728
Other Current Assets	1,137	1,085	1,149	1,503	457
Total Current Assets	21,820	22,325	22,094	19,875	17,125
Property, Plant & Equipment	22,346	21,335	19,416	17,144	15,922
Long-Term Investments	3,193	2,876	2,857	2,558	2,808
Goodwill	1,344	1,870	2,349	1,289	1,338
Other Intangible Assets	197	148	167	92	118
Long-Term Deferred Tax Assets	145	170	146	112	35
Other Long-Term Assets	1	2	1	1	2
Total Assets	49,046	48,726	47,030	41,071	37,348

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Accounts Payable	3,251	3,623	3,586	3,265	3,414
Accrued Expenses	235	197	188	170	152
Short-Term Debt	9,968	9,472	9,078	7,914	6,816
Current Portion of Long-Term Debt	8,829	8,964	519	303	182
Current Income Taxes Payable	443	475	506	368	175
Other Current Liabilities	3,097	3,261	3,745	2,834	2,479
Total Current Liabilities	25,823	25,992	17,622	14,854	13,218
Long-Term Debt	4,612	5,475	13,293	11,319	10,136
Pension & Post-Retirement Benefits	1,072	1,013	1,022	991	1,000
Long-Term Deferred Tax Liabilities	205	215	229	258	265
Other Long-Term Liabilities	900	833	908	493	285
Total Liabilities	32,612	33,528	33,074	27,915	24,904

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Common Stock	2,207	2,134	2,131	2,131	2,131
Additional Paid-In Capital	2,681	2,651	2,650	2,638	2,640
Retained Earnings	11,110	10,427	9,415	8,589	7,880
Treasury Stock	-	-255	-275	-353	-305
Comprehensive Income & Other	206	118	11	103	92
Total Common Equity	16,204	15,075	13,932	13,108	12,438
Minority Interest	230	123	24	48	6
Shareholders' Equity	16,434	15,198	13,956	13,156	12,444
Total Liabilities & Equity	49,046	48,726	47,030	41,071	37,348

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Total Debt	23,409	23,911	22,890	19,536	17,134
Net Cash (Debt)	-13,647	-12,608	-10,718	-8,354	-6,757
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-943.53	-896.23	-762.76	-594.48	-478.56
Filing Date Shares Outstanding	14.56	14.09	14.06	13.97	14.04
Total Common Shares Outstanding	14.56	14.09	14.06	13.97	14.04
Working Capital	-4,003	-3,667	4,472	5,021	3,907
Book Value Per Share	1112.86	1069.82	990.63	938.19	886.21
Tangible Book Value	14,663	13,057	11,416	11,727	10,982
Tangible Book Value Per Share	1007.03	926.61	811.73	839.35	782.47
Order Backlog	-	1,014	933.61	891.23	718.94

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error